Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
Open accessThe DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Transcriptional reprogramming of proliferative melanoma cells into a phenotypically distinct invasive cell subpopulation is a critical event at the origin of metastatic spreading. Here we generate transcriptome, open chromatin and histone modification maps of melanoma cultures; and integrate this data with existing transcriptome and DNA methylation profiles from tumour biopsies to gain insight into the mechanisms underlying this key reprogramming event. This shows thousands of genomic regulatory regions underlying the proliferative and invasive states, identifying SOX10/MITF and AP-1/TEAD as regulators, respectively. Knockdown of TEADs shows a previously unrecognized role in the invasive gene network and establishes a causative link between these transcription factors, cell invasion and sensitivity to MAPK inhibitors. Using regulatory landscapes and in silico analysis, we show that transcriptional reprogramming underlies the distinct cellular states present in melanoma. Furthermore, it reveals an essential role for the TEADs, linking it to clinically relevant mechanisms such as invasion and resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“among the SALL4-HDAC2 targets upregulated upon SALL4 knockdown, we found integrins (ITGB1, ITGA6, ITGA4), N-cadherin (CDH2), TGFBR2, VEGFR-1, PDGFC, LOXL2, MAPK8, and many others which are associated with invasive melanoma phenotypes40–42”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [41]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SALL4-regulated genes showed a significant enrichment and positive correlation with published invasiveness signatures40–42, while they significantly anti-correlated with their corresponding proliferation signatures40–42”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Cited by
Items 201–300 of 529
Metastatic melanoma moves on: translational science in the era of personalized medicine
Levesque, M. P., Cheng, P. F., Raaijmakers, M. I. G., Saltari, A., & Dummer, R. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9658-0 · Cited by 25
Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines
Noguchi, K., Dalton, A. C., Howley, B. V., McCall, B. J., Yoshida, A., Diehl, J. A., & Howe, P. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177830 · Cited by 23
Hippo Signaling Pathway Regulates Cancer Cell–Intrinsic MHC-II Expression
Zeng, Z., Gu, S. S., Ouardaoui, N., Tymm, C. C., Yang, L., Wong, C. J., Li, D., Zhang, W., Wang, X., Weirather, J. L., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0227 · Cited by 24
Jain, P., Pillai, M., Duddu, A. S., Somarelli, J. A., Goyal, Y., & Jolly, M. K. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.09.007 · Cited by 26
The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma
Wu, M., Hanly, A. M., Gibson, F. T., Fisher, R. J., Rogers, S., Park, K., Zuger, A., Kuang, K., Kalin, J. H., Nocco, S. E., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci171063 · Cited by 30
Svetlichnyy, D., Imrichova, H., Fiers, M., Kalender Atak, Z., & Aerts, S. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004590 · Cited by 22
Self-citationABCB5 is activated by MITF and β‐catenin and is associated with melanoma differentiation
Louphrasitthiphol, P., Chauhan, J. S., & Goding, C. R. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12830 · Cited by 24
BRN2 is a non-canonical melanoma tumor-suppressor
Hamm, M., Sohier, P., Petit, V., Raymond, J. H., Delmas, V., Coz, M. L., Gesbert, F., Kenny, C., Aktary, Z., Pouteaux, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23973-5 · Cited by 24
Self-citationAhn, J., Hwang, S., Cho, H., & Lee, M. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2018.133 · Cited by 21
Ferretti, L. P., Böhi, F., Pedrioli, D. M. L., Cheng, P. F., Ferrari, E., Baumgaertner, P., Alvarado-Diaz, A., Sella, F., Cereghetti, A., Turko, P., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0485 · Cited by 21
Ahn, A., Rodger, E. J., Motwani, J., Gimenez, G., Stockwell, P. A., Parry, M. F., Hersey, P., Chatterjee, A., & Eccles, M. R. (2021) · Cancers · doi:10.3390/cancers13174250 · Cited by 22
Poźniak, J., Pedri, D., Landeloos, E., Herck, Y. V., Antoranz, A., Karras, P., Nowosad, A., Makhzami, S., Bervoets, G., Dewaele, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.11.502598 · Cited by 23
Self-citationTargeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma
Raymond, J. H., Aktary, Z., Larue, L., & Delmas, V. (2022) · Cancers · doi:10.3390/cancers14030706 · Cited by 20
Mirea, M. A., Eckensperger, S., Hengstschläger, M., & Mikula, M. (2020) · Cancers · doi:10.3390/cancers12092508 · Cited by 23
Fazio, M., van Rooijen, E., Dang, M., van de Hoek, G., Ablain, J., Mito, J. K., Yang, S. P., Thomas, A., Jonathan, M., Fabo, T., et al. (2021) · eLife · doi:10.7554/elife.64370 · Cited by 21
Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stability
Berico, P., Nogaret, M., Cigrang, M., Lallement, A., Vand‐Rajabpour, F., Flores-Yanke, A., Gambi, G., Davidson, G., Seno, L., Obid, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113363 · Cited by 22
SOX10 , MITF , and microRNAs : Decoding their interplay in regulating melanoma plasticity
Lai, X., Luan, C., Zhang, Z., Wessely, A., Heppt, M. V., Berking, C., & Vera, J. (2025) · International Journal of Cancer · doi:10.1002/ijc.35499 · Cited by 17
Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer
Lin, K. C., Park, H. W., & Guan, K. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050202 · Cited by 22
Fra-2/AP-1 regulates melanoma cell metastasis by downregulating Fam212b
Chen, G., Li, R., Chen, X., Wang, J., Cao, S., Song, R., Zhao, M.-C., Li, L., Hannemann, N., Schett, G. A., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00660-4 · Cited by 21
Genes uniquely expressed in human growth plate chondrocytes uncover a distinct regulatory network
Li, B., Balasubramanian, K., Krakow, D., & Cohn, D. H. (2017) · BMC Genomics · doi:10.1186/s12864-017-4378-y · Cited by 21
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma
Phillipps, J., Nassief, G., Morecroft, R., Adeyelu, T. T., Elliott, A., Abdulla, F. R., Vanderwalde, A. M., Park, S., Butt, O. H., Zhou, A. Y., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00684-w · Cited by 19
Guetter, S., König, C., Koerkel-Qu, H., Markiewicz, A., Scheitler, S., Katzer, M., Berneburg, M., Renner, P., Cucuruz, B., Guttenberger, L., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-00963-w · Cited by 23
Kuras, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814403 · Cited by 19
Motwani, J., Rodger, E. J., Stockwell, P. A., Baguley, B. C., Macaulay, E. C., & Eccles, M. R. (2021) · Epigenomics · doi:10.2217/epi-2020-0440 · Cited by 21
CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma
Berico, P., Cigrang, M., Davidson, G., Braun, C., Sandoz, J., Gras, S. L., Vokshi, B., Slovic, N., Peyresaubes, F., Robles, C. M. G., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051683 · Cited by 19
PIEZO1 Affects Cell Growth and Migration via Microfilament-Mediated YAP trans-Latitudinal Regulation
Duan, J., Li, H., Zhang, J., Xu, H., Gao, J., Cai, M., Pan, Y., Shi, Y. C., & Wang, H. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c03420 · Cited by 18
Noguchi, K., Dincman, T. A., Dalton, A. C., Howley, B. V., McCall, B. J., Mohanty, B. K., & Howe, P. H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003616 · Cited by 17
Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Suresh, S., Rabbie, R., Garg, M., Lumaquin, D., Huang, T. H., Montal, E. D., Ma, Y., Cruz, N. M., Tang, X., Nsengimana, J., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0427 · Cited by 18
CEACAM1 is a direct SOX10 target and inhibits melanoma immune infiltration and stemness
Abou‐Hamad, J., Hodgins, J. J., de Souza, C. T., Garland, B., Labrèche, C., Marotel, M., Gibson, C., Delisle, S., Pascoal, J., Auer, R. C., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105524 · Cited by 17
Cytokine and Chemokine Receptor Patterns of Human Malignant Melanoma Cell Lines
Koroknai, V., Szász, I., Jámbor, K., & Balázs, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052644 · Cited by 16
Genomics and Epigenomics in the Molecular Biology of Melanoma—A Prerequisite for Biomarkers Studies
Zob, D., Augustin, I. G., Caba, L., Pânzaru, M.-C., Popa, S., Popa, A. D., Florea, L., & Gorduza, E. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010716 · Cited by 16
Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD
Kanai, R., Norton, E., Stern, P., Hynes, R. O., & Lamar, J. M. (2024) · Cancers · doi:10.3390/cancers16050852 · Cited by 17
Cigrang, M., Obid, J., Nogaret, M., Seno, L., Ye, T., Davidson, G., Catez, P., Berico, P., Capelli, C., Marechal, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55667-z · Cited by 17
Schwann cells in regeneration and cancer: an epithelial–mesenchymal transition perspective
Gracià, F., Sánchez‐Laorden, B. L., & Gomez-Sanchez, J. A. (2025) · Open Biology · doi:10.1098/rsob.240337 · Cited by 17
Multilayered Heterogeneity of Glioblastoma Stem Cells: Biological and Clinical Significance
Brown, D. V., Stylli, S. S., Kaye, A. H., & Mantamadiotis, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-14366-4_1 · Cited by 17
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Hashmi, M. A., Sastry, K. S., Silcock, L., Chouchane, L., Mattei, V., James, N. J., Mathew, R., Bedognetti, D., Giorgi, V. D., Murtas, D., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02350-8 · Cited by 16
Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease
Li, H., Gao, Y., Xie, L., Wang, R., Duan, R., Li, Z., Chen, B., Zhu, L., Wang, X., & Su, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.739605 · Cited by 17
PITX1 inhibits the growth and proliferation of melanoma cells through regulation of SOX family genes
Ohira, T., Nakagawa, S., Takeshita, J., Aburatani, H., & Kugoh, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-97791-6 · Cited by 17
Chen, Y., Fang, Y., Li, L., Luo, H., Cao, T., & Tu, B. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2709275 · Cited by 16
Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma
Puujalka, E., Heinz, M., Hoesel, B., Friedl, P., Schweighofer, B., Wenzina, J., Pirker, C., Schmid, J. A., Loewe, R. P., Wagner, E. F., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.01.020 · Cited by 16
Medical bioinformatics in melanoma
Cheng, P. F. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000428 · Cited by 18
Leclair, H. M., Tardif, N., Paris, A., Galibert, M., & Corre, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145025 · Cited by 16
Dysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes
Lavelle, T. J., Alver, T. N., Heintz, K., Wernhoff, P., Nygaard, V., Nakken, S., Øy, G. F., Bøe, S. L., Urbanucci, A., & Hovig, E. J. (2020) · Cancers · doi:10.3390/cancers12071719 · Cited by 17
Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis
Pillai, M., Rajaram, G., Thakur, P., Agarwal, N., Muralidharan, S., Ray, A., Barbhaya, D., Somarelli, J. A., & Jolly, M. K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.913803 · Cited by 16
Cross-species analysis of melanoma enhancer logic using deep learningPreprint
Minnoye, L., Taskiran, I. I., Mauduit, D., Fazio, M., Aerschot, L. V., Hulsemans, G., Christiaens, V., Makhzami, S., Seltenhammer, M. H., Karras, P., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.21.885715 · Cited by 16
Self-citationVasiļevska, J., Cheng, P. F., Lehmann, J., Ramelyte, E., Gómez, J. M. M., Dimitriou, F., Sella, F., Ferretti, D., Salas-Bastos, A., Jordaan, W., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101611 · Cited by 21
Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin
Raymond, J. H., Aktary, Z., Pouteaux, M., Petit, V., Luciani, F., Wehbe, M., Gizzi, P., Bourban, C., Decaudin, D., Némati, F., et al. (2025) · Nature · doi:10.1038/s41586-025-09111-x · Cited by 17
Self-citationSu, Y., Liu, C., Lu, X., Chuang, H.-Y., Li, G., Shao, S., Kong, Y., Lee, J. W., Ng, R. H., Wong, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71349-4 · Cited by 14
Sloane, R. A. S., White, M. G., Witt, R. G., Banerjee, A., Davies, M. A., Han, G., Burton, E. M., Ajami, N. J., Simon, J. M., Bernatchez, C., et al. (2021) · Cancers · doi:10.3390/cancers13215301 · Cited by 15
Li, K., Tang, M., Tong, S., Wang, C., Sun, Q., Lv, M., Sun, X., Wang, T., & Jin, S. (2020) · APOPTOSIS · doi:10.1007/s10495-019-01586-0 · Cited by 15
Katopodi, V., Marino, A., Pateraki, N., Verheyden, Y., Cinque, S., Jimenez, E. L., Adnane, S., Demesmaeker, E., Scomparin, A., Derua, R., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01377-4 · Cited by 14
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis
Loos, B., Salas-Bastos, A., Nordin, A., Debbache, J., Stierli, S., Cheng, P. F., Rufli, S., Wyss, C., Levesque, M. P., Dummer, R., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07305-1 · Cited by 14
EZH2 Inactivates Primary Cilia to Activate Wnt and Drive Melanoma
Jackson, P. K. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.06.011 · Cited by 14
Fragale, A., Stellacci, E., Romagnoli, G., Licursi, V., Parlato, S., Canini, I., Remedi, G., Buoncervello, M., Matarrese, P., Pedace, L., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34602 · Cited by 13
Rubatto, M., Borriello, S., Sciamarrelli, N., Pala, V., Tonella, L., Ribero, S., & Quaglino, P. (2023) · Melanoma Research · doi:10.1097/cmr.0000000000000926 · Cited by 14
Soumoy, L., Genbauffe, A., Mouchart, L., Sperone, A., Trelcat, A., Mukeba-Harchies, L., Wells, M., Blankert, B., Najem, A., Ghanem, G., et al. (2024) · Cancer Cell International · doi:10.1186/s12935-023-03196-y · Cited by 16
Self-citationDavidson, G., Coassolo, S., Kieny, A., Ennen, M., Pencreach, E., Malouf, G. G., Lipsker, D. M., & Davidson, I. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.01.027 · Cited by 13
Atak, Z. K., Imrichová, H., Svetlichnyy, D., Hulselmans, G. J., Christiaens, V., Reumers, J., Ceulemans, H., & Aerts, S. (2017) · Genome Medicine · doi:10.1186/s13073-017-0464-7 · Cited by 13
Self-citationPal, R. R., Kumar, A., & Misra, G. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab007 · Cited by 14
Zhu, E. Y., Riordan, J. D., Vanneste, M., Henry, M. D., Stipp, C. S., & Dupuy, A. J. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00310-7 · Cited by 14
Pigmented Lesions of the Nervous System and the Neural Crest: Lessons From Embryology
Agarwalla, P. K., Koch, M. J., Mordes, D. A., Codd, P. J., & Coumans, J.-V. C. E. (2015) · Neurosurgery · doi:10.1227/neu.0000000000001010 · Cited by 13
Decoding transcriptional states in cancer
Wouters, J., Atak, Z. K., & Aerts, S. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.01.003 · Cited by 13
Self-citationMapping convergent regulators of melanoma drug resistance by PerturbFate
Xu, Z., Lu, Z., Ugurbil, A., Abdulraouf, A., Liao, A. S.-H., Zhang, J., Zhou, W. Y., & Cao, J. (2026) · Nature · doi:10.1038/s41586-026-10367-0 · Cited by 16
Peres, J., Damerell, V., Chauhan, J. S., Popovic, A., Desprez, P., Galibert, M., Goding, C. R., & Prince, S. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.02.740 · Cited by 13
The classification of melanocytic gene signatures
Hu, M., Coleman, S. S., Judson‐Torres, R. L., & Tan, A. C. (2024) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13189 · Cited by 12
Zhou, B., Arthur, J. G., Guo, H., Kim, T., Huang, Y., Pattni, R., Wang, T., Kundu, S., Luo, J. X. J., Lee, H., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.014 · Cited by 14
Landscape of enhancer disruption and functional screen in melanoma cells
Wang, Z., Luo, M., Liang, Q., Zhao, K., Hu, Y., Wang, W., Feng, X., Hu, B., Teng, J., You, T., et al. (2023) · Genome biology · doi:10.1186/s13059-023-03087-5 · Cited by 17
Addressing erroneous scale assumptions in microbe and gene set enrichment analysis
McGovern, K. C., Nixon, M. P., & Silverman, J. D. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011659 · Cited by 14
Leveraging gene correlations in single cell transcriptomic data
Silkwood, K., Dollinger, E., Gervin, J., Atwood, S. X., Nie, Q. H., & Lander, A. D. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05926-z · Cited by 16
TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors
de Oliveira, E. A., Chauhan, J. S., da Silva, J. R., Carvalho, L. A. D. C., Dias, D., de Carvalho, D. G., Watanabe, L. R. M., Rebecca, V. W., Mills, G. B., Lu, Y., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105911 · Cited by 11
Najem, A., Wouters, J., Krayem, M., Rambow, F., Sabbah, M., Salès, F., Awada, A. H., Aerts, S., Journé, F., Marine, J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.780654 · Cited by 11
Self-citationRyu, H. J., Kim, C., Jang, H., Kim, S. I., Shin, S. J., Chung, K. Y., Torres-Cabala, C. A., & Kim, S. K. (2024) · Laboratory Investigation · doi:10.1016/j.labinv.2024.102048 · Cited by 10
Biber, P., Carminati, A., Mohager, W., Ohanna, M., Girard, C. A. J., Lecacheur, M., Kahil, M., Bouvet, O., Irondelle, M., Audebert, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116372 · Cited by 11
The genetic and epigenetic basis of distinct melanoma types
Oba, J., & Woodman, S. E. (2021) · The Journal of Dermatology · doi:10.1111/1346-8138.15957 · Cited by 12
Zhu, Q., Gao, S., & Zhang, W. (2021) · Genes · doi:10.3390/genes12091351 · Cited by 11
Aładowicz, E., Granieri, L., Marocchi, F., Punzi, S., Giardina, G., Ferrucci, P. F., Mazzarol, G., Capra, M. C., Viale, G., Confalonieri, S., et al. (2020) · Cancers · doi:10.3390/cancers12113366 · Cited by 11
Siena, Á. D. D., de Barros, I. I., Storti, C. B., de Biagi, C. A. O., Carvalho, L. A. D. C., Maria–Engler, S. S., Sousa, J. F., & Silva, W. A. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16987 · Cited by 10
Automatic detection of complex structural genome variation across world populationsPreprint
Zhou, B., Arthur, J. G., Guo, H., Hughes, C., Kim, T., Huang, Y., Pattni, R., Lee, H., Ji, H. P., Song, G., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/200170 · Cited by 12
DNA damage remodels the MITF interactome to increase melanoma genomic instability
Binet, R., Lambert, J., Tomková, M., Tischfield, S., Baggiolini, A., Picaud, S., Sarkar, S., Louphrasitthiphol, P., Dias, D., Carreira, S., et al. (2024) · Genes & Development · doi:10.1101/gad.350740.123 · Cited by 12
An in vivo avian model of human melanoma to perform rapid and robust preclinical studies
Jarrosson, L., Dalle, S., Costechareyre, C., Tang, Y., Grimont, M., Plaschka, M., Lacourrège, M., Teinturier, R., Bouar, M. L., Maucort‐Boulch, D., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216629 · Cited by 10
Clinical Implications of Primary Cilia in Skin Cancer
Choudhury, A., Neumann, N. M., Raleigh, D. R., & Lang, U. E. (2020) · Dermatology and Therapy · doi:10.1007/s13555-020-00355-1 · Cited by 11
Purwin, T. J., Caksa, S., Saçan, A., Capparelli, C., & Aplin, A. E. (2023) · iScience · doi:10.1016/j.isci.2023.107472 · Cited by 9
A bridge between melanoma cell states
Aiello, N. M., & Kang, Y. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0556-2 · Cited by 9
Sometimes even apoptosis fails: implications for cancer
Berthenet, K., Weber, K., & Ichim, G. (2020) · Molecular & Cellular Oncology · doi:10.1080/23723556.2020.1797430 · Cited by 9
Anichini, A., Caruso, F. P., Lagano, V., Noviello, T., Tufano, R., Nicolini, G., Molla, A., Bersani, I., Sgambelluri, F., Covre, A., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03474-9 · Cited by 9
Cinque, S., Verheyden, Y., Adnane, S., Marino, A., Hanache, S., Vendramin, R., Cuomo, A., Poźniak, J., Calabuig, Á. C., Baldewijns, M. M. L. L., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20251507 · Cited by 12
AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis
McRee, S. K., Bayer, A. L., Pietruska, J. R., Tsichlis, P. N., & Hinds, P. W. (2023) · Cancers · doi:10.3390/cancers15204958 · Cited by 9
Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development
Kim, G., Bhattarai, P. Y., Lim, S., Lee, K. Y., & Choi, H. S. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00910-w · Cited by 9
Seip, K., Jørgensen, K., Haselager, M. V., Albrecht, M., Haugen, M. H., Egeland, E. V., Lucarelli, P., Engebraaten, O., Sauter, T., Mælandsmo, G. M., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.023 · Cited by 8
Centore, R. C., Soares, L. M. M., Topal, S., Vaswani, R. G., Ichikawa, K., Li, Z., Fan, H. B., Setser, J. W., Lahr, D. L., Zawadzke, L. E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.11.557162 · Cited by 9
Spatial determinants of tumor cell dedifferentiation and plasticity in primary cutaneous melanomaPreprint
Vallius, T., Shi, Y., Novikov, E., Pant, S. M., Pelletier, R. J., Chen, Y., Tefft, J. B., Nirmal, A. J., Maliga, Z., Wan, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.21.660851 · Cited by 11
Ferreres, J. R., Vinyals, A., Campos-Martín, R., Espín, R., Podlipnik, S., Ramos, R., Bertrán, E., Carrera, C., Marcoval, J., Malvehy, J., et al. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13688 · Cited by 13
Expression pattern of osteopontin isoforms in malignant melanoma cell lines
Koroknai, V., Szász, I., Jámbor, K., & Balázs, M. (2023) · Clinical and Translational Science · doi:10.1111/cts.13694 · Cited by 8
Sox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses
Abou‐Hamad, J., Hodgins, J. J., Yakubovich, E., Vanderhyden, B. C., Ardolino, M., & Sabourin, L. A. (2023) · Cells · doi:10.3390/cells13010073 · Cited by 7
Polubothu, S., Al-Olabi, L., Lionarons, D. A., Harland, M., Thomas, A. C., Horswell, S. D., Hunt, L., Wlodarchak, N., Paula, A., Brand, S., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01204-y · Cited by 8
Proteomics and Phosphoproteomics Profiling of Drug-Addicted BRAFi-Resistant Melanoma Cells
Li, B., Kong, X., Post, H., Raaijmakers, L. M., Peeper, D. S., & Altelaar, M. A. F. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00331 · Cited by 8
Guendisch, U., Loos, B., Cheng, P. F., Dummer, R., Levesque, M. P., Varum, S., & Sommer, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.916033 · Cited by 7
Nuclear localization of TEF3-1 promotes cell cycle progression and angiogenesis in cancer
Teng, K., Deng, C., Xu, J., Men, Q., Lei, T., Di, D., Liu, T., Li, W., & Liu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.7342 · Cited by 7
Constructing tissue-specific transcriptional regulatory networks via a Markov random field
Ma, S., Jiang, T., & Jiang, R. (2018) · BMC Genomics · doi:10.1186/s12864-018-5277-6 · Cited by 7
Capobianco, E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050664 · Cited by 7
Metadata
- Authors
- Verfaillie, A., Imrichova, H., Atak, Z. K., Dewaele, M., Rambow, F., Hulselmans, G., Christiaens, V., Svetlichnyy, D., Luciani, F., Van den Mooter, L., Claerhout, S., Fiers, M., Journe, F., Ghanem, G.-E., Herrmann, C., Halder, G., Marine, J.-C., & Aerts, S.
- Affiliations
- KU Leuven (BE)
- VIB-KU Leuven Center for Cancer Biology (BE)
- Université Libre de Bruxelles (BE)
- German Cancer Research Center (DE)
- Corresponding author
- Aerts, Stein
- ORCID
- Venue
- Nature Communications
- Published
- 2015-04-09
- Volume
- 6
- Issue
- 1
- Pages
- 6683-6683
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4403341
- OpenAlex
- W2018433132
- Cited by
- 489
- References
- 72
- Citations by year
- 2026: 27 · 2025: 32 · 2024: 59 · 2023: 56 · 2022: 59 · 2021: 50 · 2020: 56 · 2019: 41 · 2018: 33 · 2017: 39 · 2016: 24 · 2015: 11
- FWCI
- 15.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- Funders
- Fonds Wetenschappelijk Onderzoek
- KU Leuven
- Kom op tegen Kanker
- Fondation contre le Cancer
- Stand Up To Cancer
- Bijzonder Onderzoeksfonds UGent
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- melanoma, cell invasion, transcriptional reprogramming, TEAD transcription factors, SOX10, MITF, AP-1, MAPK inhibitors, MAPK inhibitor resistance, chromatin accessibility, histone modifications, DNA methylation, metastasis
- MeSH terms
- TEA Domain Transcription Factors, Antineoplastic Agents, Cell Transformation, Neoplastic, Chromatin, DNA-Binding Proteins, Histones, Humans, Melanoma, Neoplasm Invasiveness, Nuclear Proteins, Transcription Factors, Transcription, Genetic, Signal Transduction, Gene Expression Regulation, Neoplastic, Transcription Factor AP-1, DNA Methylation, Protein Isoforms, RNA, Small Interfering, Cell Line, Tumor, Protein Kinase Inhibitors, Microphthalmia-Associated Transcription Factor, Gene Regulatory Networks, SOXE Transcription Factors, Transcriptome, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.